CareLit · DOI-Nachweis · Zeitschrift für Gastroenterologie
Sorafenib treatment and safety profile in Child Pugh B patients characterized in first interim results of GIDEON (global investigation of therapeutic decisions in hepatocellular carcinoma and of its treatment with sorafenib)
DOI 10.1055/s-0031-1285560
Bibliografische Angaben
Nachweis in CareLit
Autor:innenJP Bronowicki, HY Lim, P Stål, JM Marrero, M Kudo, A Venook, K Nakajima, SL Ye
ZeitschriftZeitschrift für Gastroenterologie
Ausgabe08/2011
Jahrgang / SeitenNicht angegeben
Kernaussage aus der Literatur
Abstract-Vorschau
Introduction: The aim of GIDEON, the largest ongoing, global, prospective, non-interventional study of patients (pts) with unresectable HCC (uHCC) eligible for systemic therapy and receiving sorafenib (Sor), is to evaluate Sor safety and efficacy in diverse real-life clinical settings and pt subgroups where data are limited, eg, Child Pugh B. Methods: Demographic data, medical, disease and treatment history are reco…
Zitieren
Zitierempfehlung
JP Bronowicki, HY Lim, P Stål, JM Marrero, M Kudo, A Venook, K Nakajima, SL Ye (2011) Sorafenib treatment and safety profile in Child Pugh B patients characterized in first interim results of GIDEON (global investigation of therapeutic decisions in hepatocellular carcinoma and of its treatment with sorafenib). Zeitschrift für Gastroenterologie (08). https://doi.org/10.1055/s-0031-1285560
Mit CareLit weiterarbeiten